Stockreport

AbbVie's Ovarian Cancer Drug Elahere Gets Approval in Europe [Yahoo! Finance]

AbbVie Inc.  (ABBV) 
Last abbvie inc. earnings: 5/1 07:43 am Check Earnings Report
US:NYSE Investor Relations: investors.abbvie.com/investor-overview
PDF The EC has approved Elahere for treating adult patients with folate receptor-alpha (FRa) positive, platinum-resistant and high-grade serous epithelial ovarian, fallopia [Read more]